Currently, out of the existing stock ratings of Brandon Henry - 41 which are a Buy (46.59%), 44 which are a Hold (50%), 3 which are a Sell (3.41%)

Brandon Henry

Work Performance Price Targets & Ratings Chart

Analyst Brandon Henry works at RBC and is covering the Healthcare sector with 235 price targets and ratings displayed on 10 stocks.

Brandon Henry's average stock forecast success ratio is 97.25% with an average time for price targets to be met of 397.1 days.

Most recent stock forecast was given on PEN, Penumbra at 18-Jul-2022.

Wall Street Analyst Brandon Henry

Analyst best performing recommendations are on NUVA (NUVASIVE).
The best stock recommendation documented was for NUVA (NUVASIVE) at 5/5/2011. The price target of $32 was fulfilled within 1 day with a profit of $1.34 (4.37%) receiving and performance score of 43.71.

Average potential price target upside

of $43.77 (33.57%) on PEN (PENUMBRA).
of $27.02 (25.73%) on ZBH (ZIMMER BIOMET HOLDINGS).
of $8.47 (6.79%) on VAR.

ISRG Intuitive Surgical NUVA NuVasive SYK Stryker VAR ZBH Zimmer Biomet Holdings BAX Baxter International MDT Medtronic plc EW Edwards Lifesciences JNJ Johnson & Johnson PEN Penumbra

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Sanjit Singh (RBC)